Mitsubishi UFJ Asset Management
SUPN icon

Mitsubishi UFJ Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.39K Hold
202
– – ﹤0.01% 1469
2026
Q1 		$10.4K Hold
202
– – ﹤0.01% 1382
2025
Q4 		$9.99K Hold
202
– – ﹤0.01% 1371
2025
Q3 		$9.65K Hold
202
– – ﹤0.01% 1352
2025
Q2 		$6.37K Hold
202
– – ﹤0.01% 1423
2025
Q1 		$6.62K Hold
202
– – ﹤0.01% 1390
2024
Q4 		$7.46K Hold
202
– – ﹤0.01% 1356
2024
Q3 		$6.3K Hold
202
– – ﹤0.01% 1370
2024
Q2 		$5.4K Hold
202
– – ﹤0.01% 1355
2024
Q1 		$6.89K Hold
202
– – ﹤0.01% 1247
2023
Q4 		$5.62K Hold
202
– – ﹤0.01% 1282
2023
Q3 		$5.57K Buy
+202
New +$6.15K ﹤0.01% 1235

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Mitsubishi UFJ Asset Management's SUPN Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 202 shares worth $9.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1469.

Mitsubishi UFJ Asset Management first reported a position in SUPN in Q3 2023 and has held it in 12 quarters since. The position peaked at $10.4K in Q1 2026. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 202 shares of Supernus Pharmaceuticals worth $9.39K as of Q2 2026.
  • Mitsubishi UFJ Asset Management left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1469 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Supernus Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Mitsubishi UFJ Asset Management's Supernus Pharmaceuticals position peaked at $10.4K in Q1 2026.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.